These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30294457)

  • 21. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries.
    Mendis S; Lindholm LH; Mancia G; Whitworth J; Alderman M; Lim S; Heagerty T
    J Hypertens; 2007 Aug; 25(8):1578-82. PubMed ID: 17620952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries.
    Suhrcke M; Boluarte TA; Niessen L
    BMC Public Health; 2012 Jan; 12():2. PubMed ID: 22214510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.
    Rosengren A; Smyth A; Rangarajan S; Ramasundarahettige C; Bangdiwala SI; AlHabib KF; Avezum A; Bengtsson Boström K; Chifamba J; Gulec S; Gupta R; Igumbor EU; Iqbal R; Ismail N; Joseph P; Kaur M; Khatib R; Kruger IM; Lamelas P; Lanas F; Lear SA; Li W; Wang C; Quiang D; Wang Y; Lopez-Jaramillo P; Mohammadifard N; Mohan V; Mony PK; Poirier P; Srilatha S; Szuba A; Teo K; Wielgosz A; Yeates KE; Yusoff K; Yusuf R; Yusufali AH; Attaei MW; McKee M; Yusuf S
    Lancet Glob Health; 2019 Jun; 7(6):e748-e760. PubMed ID: 31028013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted faith-based and faith-placed interventions for noncommunicable disease prevention and control in low- and middle-income countries: a systematic review protocol.
    Odukoya OO; Jeet G; Adebusoye B; Idowu O; Ogunsola FT; Okuyemi KS
    Syst Rev; 2022 Jun; 11(1):119. PubMed ID: 35690788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries.
    Seale AC; Hutchison C; Fernandes S; Stoesser N; Kelly H; Lowe B; Turner P; Hanson K; Chandler CIR; Goodman C; Stabler RA; Scott JAG
    Wellcome Open Res; 2017; 2():91. PubMed ID: 29181453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hand hygiene in low- and middle-income countries.
    Loftus MJ; Guitart C; Tartari E; Stewardson AJ; Amer F; Bellissimo-Rodrigues F; Lee YF; Mehtar S; Sithole BL; Pittet D
    Int J Infect Dis; 2019 Sep; 86():25-30. PubMed ID: 31189085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries.
    Alp E; Cookson B; Erdem H; Rello J;
    J Hosp Infect; 2019 Mar; 101(3):248-256. PubMed ID: 30036635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the INDEPTH HDSS to build capacity for chronic non-communicable disease risk factor surveillance in low and middle-income countries.
    Ng N; Van Minh H; Juvekar S; Razzaque A; Huu Bich T; Kanungsukkasem U; Ashraf A; Masud Ahmed S; Soonthornthada K
    Glob Health Action; 2009 Sep; 2():. PubMed ID: 20027262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
    Yoo SGK; Chung GS; Bahendeka SK; Sibai AM; Damasceno A; Farzadfar F; Rohloff P; Houehanou C; Norov B; Karki KB; Azangou-Khyavy M; Marcus ME; Aryal KK; Brant LCC; Theilmann M; Cífková R; Lunet N; Gurung MS; Mwangi JK; Martins J; Haghshenas R; Sturua L; Vollmer S; Bärnighausen T; Atun R; Sussman JB; Singh K; Saeedi Moghaddam S; Guwatudde D; Geldsetzer P; Manne-Goehler J; Huffman MD; Davies JI; Flood D
    JAMA; 2023 Aug; 330(8):715-724. PubMed ID: 37606674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoonotic spillover and viral mutations from low and middle-income countries: improving prevention strategies and bridging policy gaps.
    Haq Z; Nazir J; Manzoor T; Saleem A; Hamadani H; Khan AA; Saleem Bhat S; Jha P; Ahmad SM
    PeerJ; 2024; 12():e17394. PubMed ID: 38827296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study.
    Lear SA; Hu W; Rangarajan S; Gasevic D; Leong D; Iqbal R; Casanova A; Swaminathan S; Anjana RM; Kumar R; Rosengren A; Wei L; Yang W; Chuangshi W; Huaxing L; Nair S; Diaz R; Swidon H; Gupta R; Mohammadifard N; Lopez-Jaramillo P; Oguz A; Zatonska K; Seron P; Avezum A; Poirier P; Teo K; Yusuf S
    Lancet; 2017 Dec; 390(10113):2643-2654. PubMed ID: 28943267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
    Khatib R; McKee M; Shannon H; Chow C; Rangarajan S; Teo K; Wei L; Mony P; Mohan V; Gupta R; Kumar R; Vijayakumar K; Lear SA; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Yusoff K; Ismail N; Kazmi K; Rahman O; Rosengren A; Monsef N; Kelishadi R; Kruger A; Puoane T; Szuba A; Chifamba J; Temizhan A; Dagenais G; Gafni A; Yusuf S;
    Lancet; 2016 Jan; 387(10013):61-9. PubMed ID: 26498706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tackling the non-communicable disease epidemic: a framework for policy action in low- and middle-income countries.
    Owusu MF; Adu J; Gyamfi S; Martin-Yeboah E; Dortey BA
    Pan Afr Med J; 2024; 47():82. PubMed ID: 38737222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond.
    Gieber L; Muturi-Kioi V; Malhotra S; Sitlani A
    Pharmaceut Med; 2023 May; 37(3):203-214. PubMed ID: 37115494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weak surveillance and policy attention to cancer in global health: the example of Mozambique.
    Lorenzoni C; Oliveras L; Vilajeliu A; Carrilho C; Ismail MR; Castillo P; Augusto O; Sidat M; Menéndez C; Garcia-Basteiro AL; Ordi J
    BMJ Glob Health; 2018; 3(2):e000654. PubMed ID: 29607101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Event-based surveillance at health facility and community level in low-income and middle-income countries: a systematic review.
    Kuehne A; Keating P; Polonsky J; Haskew C; Schenkel K; Le Polain de Waroux O; Ratnayake R
    BMJ Glob Health; 2019; 4(6):e001878. PubMed ID: 31908863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to improve clinical research in surgery through international collaboration.
    Søreide K; Alderson D; Bergenfelz A; Beynon J; Connor S; Deckelbaum DL; Dejong CH; Earnshaw JJ; Kyamanywa P; Perez RO; Sakai Y; Winter DC;
    Lancet; 2013 Sep; 382(9898):1140-51. PubMed ID: 24075054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.